WebNivestym® (filgrastim-aafi) Official Site | Safety Info. NIVESTYM is a man-made form of granulocyte-colony stimulating factor (G-CSF), a substance produced by the body. It …
See results only from nivestym.comPatient Resources
Resources available to help support patients prescribed NIVESTYM Making …
About Nivestym
Why would I be prescribed NIVESTYM? NIVESTYM is a biosimilar* to …
Home
Do not take NIVESTYM ® if you have had a serious allergic reaction to human …
Using NIVESTYM
Do not take NIVESTYM ® if you have had a serious allergic reaction to human …
NIVESTYM™ (filgrastim-aafi) Medication Guide Patient information ...
WebNIVESTYM (Neye-ves-tim) (filgrastim-aafi) injection. What is NIVESTYM? NIVESTYM is a man-made form of granulocyte colony-stimulating factor (G-CSF). G-CSF is a substance …
NIVESTYM™ (filgrastim-aafi) Full Patient Information Patient ...
WebNIVESTYM (Neye-ves-tim) (filgrastim-aafi) injection. What is NIVESTYM? NIVESTYM is a man-made form of granulocyte colony-stimulating factor (G-CSF). G-CSF is a substance …
U.S. FDA Approves Pfizer’s Biosimilar NIVESTYM™ (filgrastim-aafi)
WebJul 20, 2018 · Ryan Crowe, +1 212-733-8160. Ryan.Crowe@pfizer.com. Share. Pfizer Inc. (NYSE:PFE) today announced that the United States (U.S.) Food and Drug …
- People also ask
NIVESTYM™ (filgrastim-aafi) Dosage and Administration | Pfizer
WebThe recommended dosage of NIVESTYM for the mobilization of autologous peripheral blood progenitor cells (PBPC) is 10 mcg/kg/day given by subcutaneous injection. Administer …
DailyMed - NIVESTYM- filgrastim-aafi injection, solution
WebFeb 28, 2024 · NIVESTYM is a sterile‚ clear‚ colorless‚ preservative-free liquid containing filgrastim-aafi injection for subcutaneous or intravenous use. The product is available in single-dose vials for subcutaneous or …
WebMar 4, 2024 · What Is Nivestym? Nivestym (filgrastim-aafi) is a leukocyte growth factor indicated to: decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid …
WebIn 2018, filgrastim-aafi (trade name Nivestym) was approved for use in the United States. In September 2008, Ratiograstim, Tevagrastim, Biograstim, and Filgrastim ratiopharm …
NIVESTYM™ (filgrastim-aafi) Highlights - Pfizer Medical Information
WebNIVESTYM is a leukocyte growth factor indicated to Decrease the incidence of infection‚ as manifested by febrile neutropenia‚ in patients with nonmyeloid malignancies receiving …
WebFeb 25, 2020 · Filgrastim-aafi is used to lower the chance of getting an infection in people with bone marrow problems caused by chemo. It is used to raise the number of white …
- Some results have been removed
Skip to content
